307 related articles for article (PubMed ID: 18284814)
1. The hypopigmentary action of KI-063 (a new tyrosinase inhibitor) combined with terrein.
Kim DS; Lee S; Lee HK; Park SH; Ryoo IJ; Yoo ID; Kwon SB; Baek KJ; Na JI; Park KC
J Pharm Pharmacol; 2008 Mar; 60(3):343-8. PubMed ID: 18284814
[TBL] [Abstract][Full Text] [Related]
2. Silymarin inhibits melanin synthesis in melanocyte cells.
Choo SJ; Ryoo IJ; Kim YH; Xu GH; Kim WG; Kim KH; Moon SJ; Son ED; Bae K; Yoo ID
J Pharm Pharmacol; 2009 May; 61(5):663-7. PubMed ID: 19406006
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of melanogenesis by piceid isolated from Polygonum cuspidatum.
Jeong ET; Jin MH; Kim MS; Chang YH; Park SG
Arch Pharm Res; 2010 Sep; 33(9):1331-8. PubMed ID: 20945131
[TBL] [Abstract][Full Text] [Related]
4. Transforming growth factor-beta1 decreases melanin synthesis via delayed extracellular signal-regulated kinase activation.
Kim DS; Park SH; Park KC
Int J Biochem Cell Biol; 2004 Aug; 36(8):1482-91. PubMed ID: 15147727
[TBL] [Abstract][Full Text] [Related]
5. Terrein: a new melanogenesis inhibitor and its mechanism.
Park SH; Kim DS; Kim WG; Ryoo IJ; Lee DH; Huh CH; Youn SW; Yoo ID; Park KC
Cell Mol Life Sci; 2004 Nov; 61(22):2878-85. PubMed ID: 15558216
[TBL] [Abstract][Full Text] [Related]
6. Long-term suppression of tyrosinase by terrein via tyrosinase degradation and its decreased expression.
Park SH; Kim DS; Lee HK; Kwon SB; Lee S; Ryoo IJ; Kim WG; Yoo ID; Park KC
Exp Dermatol; 2009 Jun; 18(6):562-6. PubMed ID: 19493001
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effects of 4-n-butylresorcinol on tyrosinase activity and melanin synthesis.
Kim DS; Kim SY; Park SH; Choi YG; Kwon SB; Kim MK; Na JI; Youn SW; Park KC
Biol Pharm Bull; 2005 Dec; 28(12):2216-9. PubMed ID: 16327152
[TBL] [Abstract][Full Text] [Related]
8. Lucidone, a novel melanin inhibitor from the fruit of Lindera erythrocarpa Makino.
Kumar KJ; Yang JC; Chu FH; Chang ST; Wang SY
Phytother Res; 2010 Aug; 24(8):1158-65. PubMed ID: 20077436
[TBL] [Abstract][Full Text] [Related]
9. AVS-1357 inhibits melanogenesis via prolonged ERK activation.
Kim DS; Lee HK; Park SH; Chae CH; Park KC
Pharmazie; 2009 Aug; 64(8):532-7. PubMed ID: 19746843
[TBL] [Abstract][Full Text] [Related]
10. Baicalin-induced Akt activation decreases melanogenesis through downregulation of microphthalmia-associated transcription factor and tyrosinase.
Jeong HS; Gu GE; Jo AR; Bang JS; Yun HY; Baek KJ; Kwon NS; Park KC; Kim DS
Eur J Pharmacol; 2015 Aug; 761():19-27. PubMed ID: 25934572
[TBL] [Abstract][Full Text] [Related]
11. Effect of pyrroloquinoline quinone (PQQ) on melanogenic protein expression in murine B16 melanoma.
Sato K; Toriyama M
J Dermatol Sci; 2009 Feb; 53(2):140-5. PubMed ID: 19013771
[TBL] [Abstract][Full Text] [Related]
12. Hypopigmentary effects of 4-n-butylresorcinol and resveratrol in combination.
Kim SY; Park KC; Kwon SB; Kim DS
Pharmazie; 2012 Jun; 67(6):542-6. PubMed ID: 22822544
[TBL] [Abstract][Full Text] [Related]
13. Dual hypopigmentary effects of punicalagin via the ERK and Akt pathways.
Shin JS; Cho JH; Lee H; Jeong HS; Kim MK; Yun HY; Kwon NS; Kim DS
Biomed Pharmacother; 2017 Aug; 92():122-127. PubMed ID: 28535415
[TBL] [Abstract][Full Text] [Related]
14. Hypopigmentary action of dihydropyranocoumarin D2, a decursin derivative, as a MITF-degrading agent.
Kim DS; Park SH; Lee HK; Choo SJ; Lee JH; Song GY; Yoo ID; Kwon SB; Na JI; Park KC
J Nat Prod; 2010 May; 73(5):797-800. PubMed ID: 20392068
[TBL] [Abstract][Full Text] [Related]
15. The functional property of egg yolk phosvitin as a melanogenesis inhibitor.
Jung S; Kim DH; Son JH; Nam K; Ahn DU; Jo C
Food Chem; 2012 Dec; 135(3):993-8. PubMed ID: 22953815
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory effect of the water-soluble polymer-wrapped derivative of fullerene on UVA-induced melanogenesis via downregulation of tyrosinase expression in human melanocytes and skin tissues.
Xiao L; Matsubayashi K; Miwa N
Arch Dermatol Res; 2007 Aug; 299(5-6):245-57. PubMed ID: 17333222
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the inhibition of mushroom tyrosinase and cellular tyrosinase activities of oxyresveratrol: comparison with mulberroside A.
Kim JK; Park KT; Lee HS; Kim M; Lim YH
J Enzyme Inhib Med Chem; 2012 Aug; 27(4):495-503. PubMed ID: 21827364
[TBL] [Abstract][Full Text] [Related]
18. Myriocin, a serine palmitoyltransferase inhibitor, increases melanin synthesis in Mel-Ab cells and a skin equivalent model.
Li H; Yun HY; Baek KJ; Kwon NS; Park KC; Kim DS
Pharmazie; 2014 Mar; 69(3):187-91. PubMed ID: 24716407
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory effects of 6-(3-hydroxyphenyl)-2-naphthol on tyrosinase activity and melanin synthesis.
Chung SW; Ha YM; Kim YJ; Song S; Lee H; Suh H; Chung HY
Arch Pharm Res; 2009 Feb; 32(2):289-94. PubMed ID: 19280161
[TBL] [Abstract][Full Text] [Related]
20. Manassantin A inhibits cAMP-induced melanin production by down-regulating the gene expressions of MITF and tyrosinase in melanocytes.
Lee HD; Lee WH; Roh E; Seo CS; Son JK; Lee SH; Hwang BY; Jung SH; Han SB; Kim Y
Exp Dermatol; 2011 Sep; 20(9):761-3. PubMed ID: 21569106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
